Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double-blind, phase 2 trial.
Journal: Diabetes, obesity & metabolism
Published: April 19, 2021
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes.
Journal: Clinical endocrinology
Published: November 11, 2017
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
Journal: Diabetes, obesity & metabolism
Published: April 11, 2017
Showing 1-3 of 3
Last Updated: 09/26/2026